Target intelligence / Profile preview

Immune System Activation via Immunogenic Cell Death

Molecular classification
Immune signaling pathway, Cell death pathway
01

Overview

Immunogenic cell death (ICD) is a regulated form of cell death that activates the immune system, particularly by stimulating both innate and adaptive immune responses against dying cells. Unlike non-immunogenic forms of apoptosis, ICD leads to the release or exposure of specific molecules known as damage-associated molecular patterns (DAMPs), which serve as signals to alert and activate antigen-presenting cells. Key DAMPs include calreticulin, ATP, HMGB1, and HSP70/HSP90. ICD is induced by certain chemotherapeutic agents, radiotherapy, and some biological stressors. Harnessing ICD has significant potential in cancer therapy by converting “cold” tumors into “hot” tumors responsive to immunotherapy and potentially for vaccine development against tumors due to its ability to induce robust systemic anti-tumor immunity when properly activated.

02

Mechanism of action

Induction of immunogenic cell death leading to DAMP release and immune cell activation.

03

Biological functions

Immune responseCell deathAntigen presentationInflammation
04

Disease associations

CancerInfectious disease
05

Safety considerations

Potential for excessive inflammation or autoimmunityTumor microenvironment resistanceLack of antigenicityInsufficient cytotoxicity/stress response
06

Interacting drugs

Anthracyclines

5 more in the full profile.

07

Biomarkers

Calreticulin (CALR) exposureATP releaseHMGB1 releaseHSP70/HSP90 surface expressionType I IFN levelsIL-1 family cytokine levels

Beyond the preview

Go deeper on Immune System Activation via Immunogenic Cell Death.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immune System Activation via Immunogenic Cell Death.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call